Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In rat models of colitis which mimic human IBD BPC-157 significantly sped up mucosal healing, reduced inflammatory markers, and improved the animals weight and wellbeing
It is designed for oral consumption in capsule form
The study discussed here was relatively small, involving only 17 patients, and more extensive clinical trials are needed to fully understand: Long-term safety profile Optimal dosing protocols Patient selection criteria Potential side effects Interactions with other treatments Additionally, patients should be aware that BPC-157 is not yet FDA-approved for human use, and treatment is typically offered on a research or compassionate use basis by qualified practitioners
Different mechanism entirely, but relevant for researchers interested in the intersection of aging and neuroprotection
US$ 24.91
US$ 25.85
US$ 28.04
